
Keywords: P-gp; P-glycoproteins; BEs; bioactive excipients; AP; apical; BL; basolateral; Papp; apparent permeability; CYP3A4; cytochrome P450 3A; HCC; hepatocellular carcinoma; BBB; blood-brain barrier; ER; Estrogen receptor; Cell line; Nanomedicine; Permeability